Foundation Fighting Blindness and RetroSense Therapeutics Make Progress Toward First-Ever Clinical Trial for Optogenetic Gene Therapy Treatment OWINGS MILLS, Md., May 25, 2012 (GLOBE NEWSWIRE) -- After a productive meeting this week with the U.S. Food and Drug Administration (FDA), the Foundation Fighting Blindness acknowledges a clearer path...